Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients
Learn more about:
Related Clinical Trial
Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation
Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide
Liver Stiffness Measurement Predicts VOD/SOS Development (ELASTOVOD ITALIAN MULTICENTRIC STUDY)
Ultrasound Elastography to Predict Development of SOS
5-day Defibrotide Treatment for Hepatic SOS/VOD
Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients
European VOD Registry
Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study
Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants
Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients
Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
Antithrombin-III for Patients With Hepatic Veno-occlusive Diseases Following Hematopoietic Stem Cell Transplantation
Detection of Sinusoidal Obstruction Syndrome With Ultrasound After Allogeneic HSCT
Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver
Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients